P-303 Belantamab mafodotin in patients with relapsed/refractory multiple myeloma who are triple-refractory: a retro-prospective Italian observational study

Autor:	Offidani, Massimo, Morè, Sonia, Cavo, Michele, Derudas, Daniele, Raimondo, Francesco Di, Cuneo, Antonio, Baldini, Luca, Pepa, Roberta Della, Musso, Maurizio, Boccadoro, Mario, Musto, Pellegrino, Belotti, Angelo, Fioritoni, Francesca, Renzo, Nicola Di, Mele, Anna, Gamberi, Barbara, De Paoli, Lorenzo, Zambello, Renato, Grammatico, Sara, Brociner, Marco, Fazio, Francesca, Petrucci, Maria-Teresa
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S205-S205
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect